Your search returned 13 results.

Results
	1.	Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report. [electronic resource] by Valente, Monica Catena, Laura Milione, Massimo Pusceddu, Sara Formisano, Barbara Bajetta, Emilio Publication details: Case reports in oncology Jul 2010 In: Case reports in oncology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer. [electronic resource] by Pusceddu, Sara Bajetta, Emilio Carcangiu, Maria Luisa Formisano, Barbara Ducceschi, Monika Buzzoni, Roberto Producer: 20120917 In: Critical reviews in oncology/hematology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors. [electronic resource] by Pusceddu, Sara de Braud, Filippo Concas, Laura Bregant, Cristina Leuzzi, Livia Formisano, Barbara Buzzoni, Roberto Producer: 20150515 In: Tumori vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen. [electronic resource] by Pietrantonio, Filippo Biondani, Pamela de Braud, Filippo Pellegrinelli, Alessandro Bianchini, Giampaolo Perrone, Federica Formisano, Barbara Di Bartolomeo, Maria Producer: 20121002 In: Translational oncology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer. [electronic resource] by Platania, Marco Agustoni, Francesco Formisano, Barbara Vitali, Milena Ducceschi, Monika Pietrantonio, Filippo Zilembo, Nicoletta Gelsomino, Francesco Pusceddu, Sara Buzzoni, Roberto Producer: 20120201 In: Targeted oncology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms? [electronic resource] by Catena, Laura Bichisao, Ettore Milione, Massimo Valente, Monica Platania, Marco Pusceddu, Sara Ducceschi, Monika Zilembo, Nicoletta Formisano, Barbara Bajetta, Emilio Producer: 20120405 In: Tumori vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies. [electronic resource] by Pusceddu, Sara De Braud, Filippo Lo Russo, Giuseppe Concas, Laura Femia, Daniela Vernieri, Claudio Indini, Alice Formisano, Barbara Buzzoni, Roberto Producer: 20180109 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer. [electronic resource] by Bidoli, Paolo Stani, Simonetta C Mariani, Luigi De Candis, Daniela Cortinovis, Diego Aglione, Stefania Zilembo, Nicoletta Toffolatti, Luisa Formisano, Barbara Bajetta, Emilio Producer: 20040514 In: Lung cancer (Amsterdam, Netherlands) vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? [electronic resource] by Bajetta, Emilio Catena, Laura Procopio, Giuseppe De Dosso, Sara Bichisao, Ettore Ferrari, Leonardo Martinetti, Antonia Platania, Marco Verzoni, Elena Formisano, Barbara Bajetta, Roberto Producer: 20070522 In: Cancer chemotherapy and pharmacology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes. [electronic resource] by Bajetta, Emilio Catena, Laura Ducceschi, Monika Pusceddu, Sara Milione, Massimo Maccauro, Marco Bajetta, Roberto Procopio, Giuseppe Buzzoni, Roberto Formisano, Barbara Di Guardo, Lorenza Platania, Marco Producer: 20091117 In: Tumori vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review. [electronic resource] by Pusceddu, Sara De Braud, Filippo Festinese, Fabrizio Bregant, Cristina Lorenzoni, Alice Maccauro, Marco Milione, Massimo Concas, Laura Formisano, Barbara Leuzzi, Livia Mazzaferro, Vincenzo Buzzoni, Roberto Producer: 20160411 In: Future oncology (London, England) vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes. [electronic resource] by Pusceddu, Sara Buzzoni, Roberto Vernieri, Claudio Concas, Laura Marceglia, Sara Giacomelli, Luca Milione, Massimo Leuzzi, Livia Femia, Daniela Formisano, Barbara Mazzaferro, Vincenzo de Braud, Filippo Producer: 20170301 In: Future oncology (London, England) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: a phase II study. [electronic resource] by Bajetta, Emilio Pietrantonio, Filippo Buzzoni, Roberto Ferrario, Erminia Valvo, Francesca Mariani, Luigi Dotti, Katia F Biondani, Pamela Formisano, Barbara Gevorgyan, Arpine Grassi, Paolo Di Bartolomeo, Maria Producer: 20150120 In: American journal of clinical oncology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)